Case number 1:19-cv-01199
Astellas US LLC et al v. Accord Healthcare, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 18, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [788] in Lead C.A. No. 18-1675-CFC-CJB (fms) |
| Aug 16, 2021 | 14 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal as to Accord Healthcare, Inc. by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Aug 21, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01675-CFC. ALL FILINGS SHALL BE MADE IN C.A. NO. 18-1675-CFC. (fms) |
| Aug 21, 2019 | 13 | SO ORDERED (3) Docket Text: SO ORDERED, re (12 in 1:19-cv-01199-CFC) Stipulation and Order to Consolidate Action filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. C.A. No. 19-1199-CFC and C.A. No. 18-1675-CFC are consolidated for allpurposes; All filings shall be made in C.A. No. 18-1675-CFC; Signed by Judge Colm F. Connolly on 8/21/2019. Associated Cases: 1:19-cv-01199-CFC, 1:18-cv-01675-CFC(fms) |
| Aug 15, 2019 | 12 | Stipulation (3) Docket Text: STIPULATION Consolidate Action with C.A. No. 18-1675 by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Aug 14, 2019 | 11 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Accord's Paragraph 4(b) Disclosures filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Aug 13, 2019 | 9 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Accord's Rule 26(a)(1) Initial Disclosures; and (2) Accord's Paragraph 3 Disclosures filed by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Aug 13, 2019 | 10 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Rule 26(a)(1) Initial Disclosures and Disclosures Pursuant to Paragraph 3 and 4(a) of the Delaware Default Standard for Discovery filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jul 16, 2019 | 7 | Answer to Complaint (15) Docket Text: ANSWER to [1] Complaint, by Accord Healthcare, Inc..(Dorsney, Kenneth) |
| Jul 16, 2019 | 8 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Intas Pharmaceuticals Limited for Accord Healthcare, Inc. filed by Accord Healthcare, Inc.. (Dorsney, Kenneth) |
| Jul 3, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Jun 25, 2019 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (myr) |
| Jun 25, 2019 | 1 | Main Document (13) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Accord Healthcare, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-2672838.) - filed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.. (Attachments: # (1) Exhibit, # (2) Exhibit, # (3) Exhibit, # (4) Exhibit, # (5) Civil Cover Sheet)(myr) |
| Jun 25, 2019 | 1 | Exhibit (22) |
| Jun 25, 2019 | 1 | Exhibit (22) |
| Jun 25, 2019 | 1 | Exhibit (20) |
| Jun 25, 2019 | 1 | Exhibit (18) |
| Jun 25, 2019 | 1 | Civil Cover Sheet (1) |
| Jun 25, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Jun 25, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/13/2019. Date of Expiration of Patent: 2/22/2027.Thirty Month Stay Deadline: 11/13/2021. (myr) |
| Jun 25, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183 ;US RE 47,301 E ;US 8,524,883. (myr) |
| Jun 25, 2019 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC filed by Astellas Pharma US, Inc., Astellas US LLC. (myr) |
| Jun 25, 2019 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc.. (myr) |
| Jun 25, 2019 | 1 | Complaint* (1) |
